CMTA_2014_Form_990

…drug testing in a transgenic rat model aimed at developing diagnostic applications and/or a pharmacological treatment of CMT1A disease. Region: Europe (d) Purpose of Grant: To conduct experimental therapy trial…

CMTA Resources

P.O. Box 105 Glenolden, PA 19036 800-606-2682 CMTAUSA.ORG The Driving Force Behind CMT Research. TREATMENT DRIVEN. COMMUNITY POWERED. CMTA LETTERHEAD_Final.indd 1 4/4/19 11:14 AM CMTA Resources Learn more CMTA Webinars:…

35-Year-Timeline

…six years in a row and received a 100% score for governance and transparency. The CMTA is Treatment-Driven and Partner-Focused P.O. Box 105 Glenolden, PA 19036 1-800-606-2682 cmtausa.org 2011 2012…

TMJulia_22

…to Accelerate Research (CMTA- STAR), our initiative which is striving to find effective treatments for CMT, we are also doing everything we can at the CMTA to ensure a brighter…

STAR_101

…STAR promised to speed up the pace of CMT research by capitalizing on advances in scientific knowledge and technology to find a treatment to stop the progression of CMT. Our…

2022 CMT Patient and Research Summit Bios Final

…nursery. He also resuscitates newborns when needed during high-risk deliveries. At the Fetal Treatment Center, he provides prenatal counseling to women with complicated pregnancies. Judge’s research focuses on genetic diseases…

CMTEEN_Volume2_Issue2_DT

…room where afflicted lab mice are examined to track the effect of their treatments. But the research facility was the most anticipated stop of the tour. Burgess’s lab was packed…

Audited Financials

…information regarding CMT disorders. The Association encourages, promotes and supports research into the cause, treatment and cure of CMT disorders. The Association also facilitates education and support for persons affected…

2021Sanders

…support, public education, promotion of research and ultimately treatments for and the cure of CMT. MAIL IN DONATIONS (USE THE ENCLOSED ENVELOPE), OR, SUBMIT FORM TO: CMTA, PO BOX 105,…

GAN Community Letter 31JAN2022 Final

…treatment of giant axonal neuropathy (GAN). The trial is being conducted by the National Institute of Neurological Disorders and Stroke (NINDS) division of the National Institutes of Health (NIH). This…